🔎 Trials Near Me

Akèy › Hyperlipoprotéinémie de type II › Utah

Etid klinik pou Hyperlipoprotéinémie de type II nan Utah

3 etid pou Hyperlipoprotéinémie de type II ap chèche patisipan nan sit nan Utah.

Vil nan Utah

Tèks ofisyèl etid la (Anglè)

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  • Primary Childrens Medical Center, Salt Lake City
Ap rekriteFaz 3
Laj 2 a 100 · Tout sèks · Mizajou Sep 18, 2026 · NCT05682378

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

  • Primary Childrens Medical Center, Salt Lake City
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  • Primary Childrens Medical Center, Salt Lake City
  • Primary Childrens Medical Center, Salt Lake City
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.